The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline
Massimo Di Maïo(A. O. Ordine Mauriziano di Torino), Ethan Basch(UNC Lineberger Comprehensive Cancer Center), Fabrice Denis(Centre Jean Bernard), Lesley Fallowfield(University of Sussex), Patricia A. Ganz(University of California, Los Angeles), Doris Howell(Princess Margaret Cancer Centre), Christoph Kowalski(German Cancer Society), Francesco Perrone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Angela M. Stover(UNC Lineberger Comprehensive Cancer Center), Puma Sundaresan(Westmead Hospital), Lorraine Warrington(St James's University Hospital), L. Zhang(Sun Yat-sen University Cancer Center), Kathi Apostolidis(European CanCer Organisation), J. Freeman-Daily, Carla Ripamonti(Fondazione IRCCS Istituto Nazionale dei Tumori), Daniele Santini(Università Campus Bio-Medico)
Cited by 472Open Access
Abstract
This ESMO Guideline provides key recommendations on the role of PROMs during the care of patients with cancer. It covers the use of PROMs in patients with cancer from the start of active treatment during follow-up and at the end of life. Recommendations are based on available scientific evidence and the authors’ collective expert consensus. Authorship includes a multidisciplinary group of experts from Europe, North America, Asia and Australia.
Related Papers
No related papers found
Powered by citation graph analysis